Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 924,000 | 901,000 | 951,000 | 895,000 | 863,000 |
| Receivables | 327,000 | 317,000 | 311,000 | 292,000 | 310,000 |
| Inventories | 78,000 | 76,000 | 72,000 | 69,000 | 52,000 |
| TOTAL | $1,329,000 | $1,294,000 | $1,334,000 | $1,256,000 | $1,225,000 |
| Non-Current Assets | |||||
| PPE Net | 57,000 | 56,000 | 55,000 | 57,000 | 54,000 |
| Intangibles | 84,000 | 112,000 | 108,000 | 107,000 | 92,000 |
| Other Non-Current Assets | 77,000 | 93,000 | 85,000 | 79,000 | 73,000 |
| TOTAL | $218,000 | $261,000 | $248,000 | $243,000 | $219,000 |
| Total Assets | $1,547,000 | $1,555,000 | $1,582,000 | $1,499,000 | $1,444,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,000 | 5,000 | 5,000 | 5,000 | 5,000 |
| Accounts payable and accrued liabilities | 721,000 | 660,000 | 644,000 | 620,000 | 665,000 |
| Other current liabilities | 69,000 | 186,000 | 189,000 | 138,000 | 143,000 |
| TOTAL | $818,000 | $918,000 | $889,000 | $806,000 | $854,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 237,000 | 324,000 | 472,000 | 478,000 | 477,000 |
| Other Non-Current Liabilities | 426,000 | 265,000 | 264,000 | 316,000 | 316,000 |
| TOTAL | $663,000 | $589,000 | $736,000 | $794,000 | $793,000 |
| Total Liabilities | $1,481,000 | $1,507,000 | $1,625,000 | $1,600,000 | $1,647,000 |
| Shareholders' Equity | |||||
| Common Shares | 73,000 | 73,000 | 73,000 | 73,000 | 72,000 |
| Retained earnings | 1,315,000 | 1,288,000 | 1,199,000 | 1,126,000 | 1,032,000 |
| Other shareholders' equity | -1,327,000 | -1,317,000 | -1,319,000 | -1,303,000 | -1,309,000 |
| TOTAL | $66,000 | $48,000 | $-43,000 | $-101,000 | $-203,000 |
| Total Liabilities And Equity | $1,547,000 | $1,555,000 | $1,582,000 | $1,499,000 | $1,444,000 |